A phase 1 study of anti-TGFβ receptor type-II monoclonal antibody LY3022859 in patients with advanced solid tumors-Reference-Cited by-同舟云学术

A phase 1 study of anti-TGFβ receptor type-II monoclonal antibody LY3022859 in patients with advanced solid tumors

Published:2017-03-09 Issue:4 Volume:79 Page:673-680
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Tolcher Anthony W.,Berlin Jordan D.,Cosaert Jan,Kauh John,Chan Emily,Piha-Paul Sarina A.,Amaya Alex,Tang Shande,Driscoll Kyla,Kimbung Richard,Kambhampati S. R. Prasad,Gueorguieva Ivelina,Hong David S.

Funder

Eli Lilly and Company

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-017-3245-5.pdf

Reference18 articles.

1. Massagué J (2008) TGFβ in cancer. Cell 134:215–230

2. Wrzesinski SH, Wan YY, Flavell RA (2007) Transforming growth factor-β and the immune response: implications for anticancer therapy. Clin Cancer Res 13:5262–5270

3. Elliott RL, Blobe GC (2005) Role of transforming growth factor beta in human cancer. J Clin Oncol 23:2078–2093

4. Inman GJ (2011) Switching TGFB from a tumor suppressor to a tumor promoter. Curr Opin Genet Dev 21:93–99

5. Teicher BA (2007) Transforming growth factor-beta and the immune response to malignant disease. Clin Cancer Res 13:6247–6251

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structure, unique biological properties, and mechanisms of action of transforming growth factor β;Bioorganic Chemistry;2024-09

2. TGF-β Modulated Pathways in Colorectal Cancer: New Potential Therapeutic Opportunities;International Journal of Molecular Sciences;2024-07-05

3. Corneal fibrosis: From in vitro models to current and upcoming drug and gene medicines;Advanced Drug Delivery Reviews;2024-06

4. Advances and Challenges in Targeting TGF-β Isoforms for Therapeutic Intervention of Cancer: A Mechanism-Based Perspective;Pharmaceuticals;2024-04-20

5. TGF-β signaling in health, disease and therapeutics;Signal Transduction and Targeted Therapy;2024-03-22